Report: Increases in Drug Rebates Associated with Rise in list Prices
February 27th 2020According to a new report from the Leonard D. Schaeffer Center for Health Policy and Economics, a $1 increase in drug rebates was associated with a $1.17 rise in list prices, hurting uninsured patients who pay list prices and insured patients who pay coinsurance and deductibles based on list prices.
Read More
FDA Approves sNDA for Neratinib as Therapy for HER2-Positive Metastatic Breast Cancer
February 27th 2020Officials from the FDA have approved a supplemental New Drug Application (sNDA) for neratinib (NERLYNX, Puma Biotechnology) in combination with capecitabine for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer that have received 2 or more prior anti-HER2-based regimens in the metastatic setting.
Read More
Tip of the Week: Avoiding Legal, Financial Difficulties With Ethical Decisions
February 27th 2020In the matter of California State Board of Pharmacy vs Pacifica Pharmacy and Thang Tran, action was taken by the board against a pharmacist accused of poor oversight, and judgment over occurrences at a community pharmacy under his watch.
Read More
Survey Shows Patients Are Unaware of Resources Offered by Manufacturers of Medications
February 26th 2020A recent patient survey conducted by Human Care Services uncovered a genuine significant desire from patients for help from drug manufacturers in managing their conditions and drug regimens.
Read More